Description: Alpa Laboratories Limited engages in manufacturing, marketing, and selling pharmaceutical finished dosage forms in India. It offers ethical, generic, and over the counter products in various finished dosage forms, including liquid injections, dry powder injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human use; and boluses, injections, and intra-mammary infusions for veterinary use. The company provides its products in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, anti protozoans, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. Alpa Laboratories Limited sells its products through distributors, as well as retail chemists, retail pharmacy stores, and hospitals. The company also exports its products to various countries in South and Central America, Africa, and Asia, including CIS countries comprising Russia, Ukraine, Kazakhstan, etc. Alpa Laboratories Limited was incorporated in 1988 and is based in Indore, India.
Home Page: www.alpalabs.in
33/2 Pigdamber
Indore,
453446
India
Phone:
91 73 1429 4567
Officers
| Name | Title |
|---|---|
| Mr. Mahendra Singh Chawla | Chairman & Compliance Officer |
| Mr. Paresh Chawla | MD & Director |
| Mr. Bakulesh C. Shah | Chief Financial Officer |
| Mr. Pravin C. Shah | Exec. Director |
| Mr. Pradeep Soni | Gen. Mang. of Production |
Exchange: BSE
Country: IN
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 20.1817 |
| Price-to-Book MRQ: | 0.7746 |
| Price-to-Sales TTM: | 0.948 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 391 |